118 related articles for article (PubMed ID: 8210636)
1. Immunophenotypic and immunogenotypic detection of minimal residual disease in acute lymphoblastic leukemia.
van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H
Recent Results Cancer Res; 1993; 131():157-84. PubMed ID: 8210636
[No Abstract] [Full Text] [Related]
2. A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.
Guidal C; Vilmer E; Grandchamp B; Cavé H
Leukemia; 2002 Apr; 16(4):762-4. PubMed ID: 11960365
[No Abstract] [Full Text] [Related]
3. Cytogenetic abnormalities during clinical, immunophenotypic, and molecular remission in pediatric acute lymphoblastic leukemia.
Sandoval C; Mayer SP; Giamelli J; Farley T; Ozkaynak MF; Tugal O; Jayabose S
Cancer Genet Cytogenet; 2000 Apr; 118(1):9-13. PubMed ID: 10731583
[TBL] [Abstract][Full Text] [Related]
4. Detection of minimal residual disease in ALL.
Deane M; Hoffbrand AV
Cancer Treat Res; 1993; 64():135-70. PubMed ID: 8095791
[No Abstract] [Full Text] [Related]
5. Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia.
Pane F; Frigeri F; Camera A; Sindona M; Brighel F; Martinelli V; Luciano L; Selleri C; Del Vecchio L; Rotoli B; Salvatore F
Leukemia; 1996 Apr; 10(4):741-5. PubMed ID: 8618457
[No Abstract] [Full Text] [Related]
6. [Immunophenotypic and immunogenotypic analyses of acute leukemia and lymphoblastic lymphoma expressing myeloid and lymphoid antigens].
Kawamura K; Tobinai K
Rinsho Byori; 1992 Jul; 40(7):761-8. PubMed ID: 1507495
[TBL] [Abstract][Full Text] [Related]
7. Posttherapy surveillance of B-cell precursor acute lymphoblastic leukemia. Value of polymerase chain reaction and limitations of flow cytometry.
Kallakury BV; Hartmann DP; Cossman J; Gootenberg JE; Bagg A
Am J Clin Pathol; 1999 Jun; 111(6):759-66. PubMed ID: 10361511
[TBL] [Abstract][Full Text] [Related]
8. Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experience.
Campana D; Neale GA; Coustan-Smith E; Pui CH
Leukemia; 2001 Feb; 15(2):278-9. PubMed ID: 11236945
[No Abstract] [Full Text] [Related]
9. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping.
Malec M; van der Velden VH; Björklund E; Wijkhuijs JM; Söderhäll S; Mazur J; Björkholm M; Porwit-MacDonald A
Leukemia; 2004 Oct; 18(10):1630-6. PubMed ID: 15295608
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin VH gene replacements in a T-cell lymphoblastic lymphoma.
Rosenquist R; Lindh J; Roos G; Holmberg D
Mol Immunol; 1997 Mar; 34(4):305-13. PubMed ID: 9244343
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous immunoglobulin/T-cell receptor gene rearrangements and multiclonality in childhood acute lymphoblastic leukemia.
Forestier E; Nordenson I; Lindström A; Roos G; Lindh J
Acta Paediatr; 1994 Mar; 83(3):319-26. PubMed ID: 8038538
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual leukemia by polymerase chain reactions.
Bartram CR; Yokota S; Hansen-Hagge TE; Janssen JW
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():4-8. PubMed ID: 2143955
[No Abstract] [Full Text] [Related]
13. [Tandem application of flow cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Jiang LM; Zhao JC; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):246-50. PubMed ID: 19374803
[TBL] [Abstract][Full Text] [Related]
14. [Identification of immunoglobulin and T-cell receptor gene rearrangements--prerequisite for monitoring of minimal residual disease in Polish acute lymphoblastic leukemia patients based on European standards. Preliminary results].
Dawidowska M; Derwich K; Szczepański T; Jółkowska J; Witt M; Wachowiak J
Med Wieku Rozwoj; 2006; 10(1 Pt 2):323-34. PubMed ID: 17028396
[TBL] [Abstract][Full Text] [Related]
15. Detection of minimal residual disease in acute leukemia patients.
van Dongen JJ; Szczepański T; de Bruijn MA; van den Beemd MW; de Bruin-Versteeg S; Wijkhuijs JM; Tibbe GJ; van Gastel-Mol EJ; Groeneveld K; Hooijkaas H
Cytokines Mol Ther; 1996 Jun; 2(2):121-33. PubMed ID: 9384697
[TBL] [Abstract][Full Text] [Related]
16. Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy.
Assumpção JG; Ganazza MA; de Araújo M; Silva AS; Scrideli CA; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2010 Dec; 55(7):1278-86. PubMed ID: 20730889
[TBL] [Abstract][Full Text] [Related]
17. Origin of a central nervous system lymphoid neoplasm in an immunocompromised host with acute lymphoblastic leukemia.
Mayer SP; Jayabose S; Tugal O; Ozkaynak MF; Rosenblum-Vos L; Sandoval C
Leuk Lymphoma; 2002 Sep; 43(9):1881-4. PubMed ID: 12685849
[TBL] [Abstract][Full Text] [Related]
18. [The current criteria of cell identification in acute lymphoblastic leukemia].
Muskhelishvili LV; Muskhelishvil GD; Sharashidze LK
Eksp Onkol; 1989; 11(1):6-11. PubMed ID: 2647463
[TBL] [Abstract][Full Text] [Related]
19. Gene rearrangements in T-cell lymphoblastic lymphoma.
Pilozzi E; Müller-Hermelink HK; Falini B; de Wolf-Peeters C; Fidler C; Gatter K; Wainscoat J
J Pathol; 1999 Jul; 188(3):267-70. PubMed ID: 10419594
[TBL] [Abstract][Full Text] [Related]
20. [Technical scheme of minimal residual disease detection with Ig/TCR rearrangements as molecular targets in childhood acute lymphoblastic leukemia].
Li ZG; Cui L; Gao C
Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):165-9. PubMed ID: 21575362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
